Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD

Let’s Talk Ophthalmology: an Evolve Medical Education Podcast
15/08/2024 11 min
Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD

Listen "Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD"

Descargar episodio Ver en sitio original

Episode Synopsis

David Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration.

This activity is supported by an independent medical education grant from Ocular Therapeutix.

Click here to view the webinar event, which includes images from the talk.

Want to register with Evolve Medical Education? Click here.

More episodes of the podcast Let’s Talk Ophthalmology: an Evolve Medical Education Podcast

Adapting to Progress: Vorolanib Intravitreal Implant 16/01/2025
Adapting to Progress: Gene Therapy for nAMD 15/08/2024
Adapting to Progress: Evolving nAMD Trials Amid Therapeutic Expansion 25/06/2024
Consensus Conversations: Neurotrophic Keratitis: Implementing Best Practices 30/04/2024
Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents 30/04/2024
Consensus Conversations: Treating Stage 1 Neurotrophic Keratitis 30/04/2024
Diabetic Macular Edema 08/03/2024
Managing AMD: Integrating Newer Therapies 08/03/2024
KOL KNOCKOUT™: Cataract Edition | Aligning Patient Preferences and Ocular Characteristics for Optimal IOL Matchmaking - Round 3 Final Round 28/02/2024
KOL KNOCKOUT™: Cataract Edition | Aligning Patient Preferences and Ocular Characteristics for Optimal IOL Matchmaking - Round 2 28/02/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA